share_log

HC Wainwright & Co. Maintains Buy on Fortress Biotech, Raises Price Target to $26

HC Wainwright & Co. Maintains Buy on Fortress Biotech, Raises Price Target to $26

HC Wainwright & Co.维持对fortress biotech的买入评级,将价格目标提高至26美元
Benzinga ·  11/18 20:45  · 评级/大行评级

HC Wainwright & Co. analyst Joseph Pantginis maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and raises the price target from $24 to $26.

HC Wainwright & Co. 分析师Joseph Pantginis维持对Fortress Biotech(纳斯达克:FBIO)的买入评级,并将目标股价从24美元提高到26美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发